INVITRO PRODUCTIVE INFECTION OF HUMAN-MALIGNANT TROPHOBLASTIC CELL-LINE JAR WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)

被引:0
|
作者
ZACHAR, V [1 ]
EBBESEN, P [1 ]
机构
[1] DANISH CANC SOC, DEPT VIRUS & CANC, AARHUS, DENMARK
关键词
TROPHOBLAST; CHORIOCARCINOMA; HIV; PCR;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human choriocarcinoma cells of the JAR line, with no demonstrable surface CD4 receptor were infected with human immunodeficiency virus type 1 (HIV-1), strain RF. Primer-directed enzymatic DNA amplification (polymerase chain reaction, PCR) detected the presence of viral DNA when the cultures were investigated at day 5 post-infection (p.i.). The absence of cytopathic changes attributable to virus replication suggested silent infection of these malignant trophoblastic cells. Neither reverse transcriptase (RT) activity nor HIV-specific antigens were found in the culture nutrient medium during JAR cell propagation. However, when the HIV-carrier JAR cells were continously cultured and the cocultivation was initiated with CEM-SS lymphoblastoid cells after two subsequent passages, rescue of infectious virus was observed.
引用
收藏
页码:464 / 468
页数:5
相关论文
共 50 条
  • [41] Genomic diversity of human immunodeficiency virus type-1 in India
    Sahni, AK
    Prasad, VVSP
    Seth, P
    INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (02) : 115 - 118
  • [42] Vectors derived from the human immunodeficiency virus, HIV-1
    Barker, E
    Planelles, V
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 : D491 - D510
  • [43] Seronegative Infection with Toxoplasma gondii in Asymptomatic Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Patients and in Blood Donors
    Pawelczyk, Agnieszka
    Bednarska, Malgorzata
    Caraballo Cortes, Kamila
    Glamkowska-Sady, Marianna
    Kowalska, Justyna
    Uszynska-Kaluza, Beata
    Radkowski, Marek
    Welc-Faleciak, Renata
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [44] PRIMARY IN-VITRO SENSITIZATION OF HUMAN T-HELPER LYMPHOCYTES BY PEPTIDES DERIVED FROM THE V3 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENVELOPE GLYCOPROTEIN
    BILLAUD, JN
    YAGELLO, M
    GLUCKMAN, JC
    VACCINE, 1994, 12 (01) : 46 - 55
  • [45] CONSTRUCTION AND CHARACTERIZATION OF A SALMONELLA TYPHI-BASED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VECTOR VACCINE
    FOUTS, TR
    LEWIS, GK
    HONE, DM
    VACCINE, 1995, 13 (06) : 561 - 569
  • [46] Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)
    Yamaguchi, K
    Honda, M
    Ikigai, H
    Hara, Y
    Shimamura, T
    ANTIVIRAL RESEARCH, 2002, 53 (01) : 19 - 34
  • [47] Quantitative Live-Cell Imaging of Human Immunodeficiency Virus (HIV-1) Assembly
    Baumgaertel, Viola
    Mueller, Barbara
    Lamb, Don C.
    VIRUSES-BASEL, 2012, 4 (05): : 777 - 799
  • [48] RISK-FACTORS FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) INFECTION IN PATIENTS AT A SEXUALLY-TRANSMITTED DISEASE CLINIC IN NEW-YORK-CITY
    CHIASSON, MA
    STONEBURNER, RL
    LIFSON, AR
    HILDEBRANDT, DS
    EWING, WE
    SCHULTZ, S
    JAFFE, HW
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (02) : 208 - 220
  • [49] VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, HIV-1
    RIVIERE, Y
    CELLULAR AND MOLECULAR BIOLOGY, 1994, 40 : 45 - 48
  • [50] MULTIPLE SUPERINFECTIONS FAIL TO ACTIVATE DEFECTIVE HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) INFECTION OF RABBITS
    SELL, S
    TSENG, CK
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 9 (03): : 211 - 226